Although the endotoxin activity of LPS is the “visible tip” of the iceberg in GVHD, quantification of whole LPS with the HPLC method associated with the LAL assay gives the opportunity to assess the potency of LPS detoxification by the PLTP in experimental GVHD models and further in transplanted patients. Here, PLTP is linked to graft versus host disease.